论文信息 - Bendamustine, Bortezomib and Dexamethasone (BVD) in Patients with Relapsed-Refractory Multiple Myeloma (MM): Updated Results of a Multicenter Phase II Study - 字舞流文

Bendamustine, Bortezomib and Dexamethasone (BVD) in Patients with Relapsed-Refractory Multiple Myeloma (MM): Updated Results of a Multicenter Phase II Study

F. Alesiani | S. Felici | P. Tosi | A. Ledda | M. Offidani | S. Pulini | P. Fraticelli | S. Galimberti | R. Rizzi | P. Leoni | A. Gozzetti | P. Mondello | I. Attolico | D. Derudas | C. Cellini | L. Corvatta | S. Ballanti | S. Gentili | M. Brunori | A. Mele | L. Maracci | P. Caraffa | L. Malerba | U. Coppetelli | T. C. D. Toritto | Liberati Anna Marina